Ra Medical Systems, Inc. (RMED): Price and Financial Metrics

Ra Medical Systems, Inc. (RMED)

Today's Latest Price: $6.76 USD

0.54 (8.68%)

Updated Dec 4 7:00pm

Add RMED to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMED Stock Summary

  • RMED's went public 2.19 years ago, making it older than just 5.21% of listed US stocks we're tracking.
  • The volatility of Ra Medical Systems Inc's share price is greater than that of 99.62% US stocks with at least 200 days of trading history.
  • Ra Medical Systems Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -126.53%, greater than the shareholder yield of only 3% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Ra Medical Systems Inc, a group of peers worth examining would be ECOR, TWOU, XENT, LEAF, and WEI.
  • RMED's SEC filings can be seen here. And to visit Ra Medical Systems Inc's official web site, go to www.ramed.com.

RMED Stock Price Chart Interactive Chart >

Price chart for RMED

RMED Price/Volume Stats

Current price $6.76 52-week high $67.20
Prev. close $6.22 52-week low $4.25
Day low $6.23 Volume 204,458
Day high $7.05 Avg. volume 143,730
50-day MA $5.99 Dividend yield N/A
200-day MA $14.73 Market Cap 19.73M

Ra Medical Systems, Inc. (RMED) Company Bio

RA Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is based in Carlsbad, California.

RMED Latest News Stream

Event/Time News Detail
Loading, please wait...

RMED Latest Social Stream

Loading social stream, please wait...

View Full RMED Social Stream

Latest RMED News From Around the Web

Below are the latest news stories about Ra Medical Systems Inc that investors may wish to consider to help them evaluate RMED as an investment opportunity.

The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3) Akouos Inc (NASDAQ: AKUS ) FibroGen Inc (NASDAQ: FGEN )(reacted to an adverse clinical readout for a rival drug to treat chronic kidney disease related anemia) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Sutro Biopharma Inc (NASDAQ: STRO ) ( reacted to announcement concerning presentation of positive data for ovarian cancer drug) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 3) Akebia Therapeutics Inc (NASDAQ: AKBA ) (announced negative safety results for a late-stage study of drug to treat chronic kidney disease-induced anemia) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Genfit SA (NASDA...

Benzinga | September 4, 2020

Ra Medical Systems, Inc. (RMED) CEO Jonathan McGuire on Q2 2020 Results - Earnings Call Transcript

Ra Medical Systems, Inc. (RMED) Q2 2020 Earnings Conference Call August 11, 2020, 16:30 ET Company Participants Jody Cain - Lippert/Heilshorn & Associates Jonathan McGuire - CEO & Director Andrew Jackson - CFO Conference Call Participants Andrew Stafford - Piper Sandler & Co. Anthony Vendetti - Maxim Group Presentation Operator...

SA Transcripts on Seeking Alpha | August 12, 2020

Ra Medical Systems prices upsized public offering

Ra Medical Systems ([[RMED]] -10.9%) priced public offering of 34.3M shares, along with its accompanying warrants, at $0.35/share; gross proceeds of ~$12M.Warrants, immediately exercisable, have an exercise price of $0.35/share; five years expiry from issuance date.Offering is expected to close on or about August 3, 2020.Proceeds will be used for...

Seeking Alpha | July 30, 2020

Ra Medical Systems Announces Pricing of $12.0 Million Upsized Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 34,285,714 sh

Business Wire | July 30, 2020

The Law Offices of Frank R. Cruz Announces Investigation of Ra Medical Systems, Inc. (RMED)

LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED) concerning whether the board breached its fiduciary duty to shareholders. If you are a shareholder, click here for more information. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Ra Medical securities, have information or would like to learn more about these claims, or ha

Business Wire | June 24, 2020

Read More 'RMED' Stories Here

RMED Price Returns

1-mo 42.32%
3-mo -3.39%
6-mo -54.93%
1-year -77.65%
3-year N/A
5-year N/A
YTD -76.07%
2019 -85.79%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7359 seconds.